Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas

[1]  T. Yorifuji,et al.  Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017–2018): Congenital hyperinsulinism, insulinoma, non‐insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease) , 2019, Journal of diabetes investigation.

[2]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  P. Bhosale,et al.  State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors. , 2016, Surgical oncology clinics of North America.

[4]  K. Hussain,et al.  Hyperinsulinemic Hypoglycemia – The Molecular Mechanisms , 2016, Front. Endocrinol..

[5]  C. V. van Eijck,et al.  New-onset diabetes after distal pancreatectomy: a systematic review. , 2015, Annals of surgery.

[6]  M. Büchler,et al.  A Systematic Review of Localization, Surgical Treatment Options, and Outcome of Insulinoma , 2014, Pancreas.

[7]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[8]  M. Falconi,et al.  Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. , 2012, Archives of surgery.

[9]  S. Libutti,et al.  Insulinoma: pathophysiology, localization and management. , 2010, Future oncology.

[10]  P. Cryer,et al.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[11]  G. Valk,et al.  Multiple Endocrine Neoplasia Type 1 (MEN 1) , 2009 .

[12]  R. Dankner,et al.  Insulin Resistance and Hyperinsulinemia , 2008, Diabetes Care.

[13]  V. Deshpande,et al.  Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital , 2008, Annals of surgery.

[14]  王炳煌.  Insulinoma , 2004 .

[15]  J. Rastad,et al.  Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes , 1992, World Journal of Surgery.

[16]  D. Ballard,et al.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.

[17]  D. Galbut,et al.  Insulinoma: diagnosis, surgical management and long-term follow-up. Review of 41 cases. , 1980, American journal of surgery.

[18]  M. Davi’,et al.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update , 2016, Journal of Endocrinological Investigation.

[19]  E. Kelly,et al.  an update on , 2014 .

[20]  F. Greenway,et al.  An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .

[21]  Clive S. Grant.  Insulinoma. , 2005, Best practice & research. Clinical gastroenterology.